Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...serious adverse events (SAEs).
more
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
ECDC MISSION REPORT 19–21 September 2016 ; 14–15 November 2016
Case Studies on Building Resilience in the Horn of Africa
Accessibility is by law; not just a favour. The booklet contains what the laws say about physical accessibility and their interpretation
International Conference on AIDS and STIs in Africa (ICASA) 2013 | 7th – 12th December | Cape Town, South Africa
Summary of key informant interviews with representatives of organizations providing, funding, or supporting WASH services to refugee populations